FKBP5 and psychiatric disorder: While there is strong evidence for increased FKBP5/1 expression (via genetic and epigenetic factors) contributing to psychiatric disease risk [76], how these factors coalesce in the human brain, especially in a cell type-specific manner, to raise risk to psychopathology or contribute to specific symptom domains is unknown.